The clinicopathological features and survival of Castleman disease: a multicenter Turkish study.
Yildiz J, Bagci M, Sayin S, Kaya A, Yilmaz F, Ekinci O, Dal MS, Basturk A, Aydogdu I, Albayrak M, Dogan A, Erkurt MA, Korkmaz S, Ulas T, Eser B, Altuntas F.
Yildiz J, et al.
Eur Rev Med Pharmacol Sci. 2022 Feb;26(4):1131-1137. doi: 10.26355/eurrev_202202_28103.
Eur Rev Med Pharmacol Sci. 2022.
PMID: 35253168
Free article.